The serotoninergic syndrome;Le syndrome serotoninergique

Journal de Pharmacie Clinique

Volumn 16, Issue 1, 1997, Pages 13-18

  Magron, P ^a   Hida, H ^a   De Beauchamp, I ^a  

^a CHS de Saint Egreve   (France)

Author keywords

drug interactions; proserotoninergic drugs; serotonin; serotonin syndrome

Indexed keywords

CYPROHEPTADINE; METHYSERGIDE; PROPRANOLOL; SEROTONIN; SEROTONIN AGONIST; UNINDEXED DRUG;

AGITATION; CENTRAL NERVOUS SYSTEM; CONFUSION; DRUG WITHDRAWAL; HUMAN; HYPERREFLEXIA; MYOCLONUS; REVIEW; SEROTONIN SYNDROME;

EID: 0030942647     PISSN: 02911981     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Meunier JM, Shvaloff A. Sérotonine. In : Neurotransmetteurs Masson éd. Paris 1992: 137-45.
2. Martin P, Lemonier F. Intérêt des récepteurs sérotoninergiques de type 2: 5HT 2a et 5HT 2c, dans les troubles dépressifs : action de la médifoxamine. L'encéphale 1994; 20: 427-35.
3. Cuche H, Séminaire de psychiatrie biologique, hôpital Sainte-Anne, Edition Médicales Fournier frères, Gennevilliers, 1981, tome 1, 107-25.
4. Borne RF Serotonin: the neurotransmitter for the '90 s. Drug topics 1994; 10: 108-20.
5. Hoyer D, Clarke DE, Fozard JR, Hartig PR Martin GR, Mylecharane EJ, et al. International union of pharmacology : classification of receptors for 5 hydroxytryptamine (serotonin). Pharmacol Rev 1994; 46: 157-205.
6. Bodner RA, Lynch T, Lewis L, Kahn D. Serotonin syndrome. Neurology 1995; 45: 219-23.
7. Lejoyeux M, Rouillon F, Adès J. Syndrome sérotoninergique et inhibiteurs de la monoamine oxydase. Neuropsy 1996; 11: 89-96.
8. Sternbach H, The serotonin syndrome. Am J Psychiatry 1991; 148: 705-13.
9. Lejoyeux M, Rouillon F, Leon N, Adès J. Le syndrome sérotoninergique: revue de la littérature et description d'une étude originale. L'encéphale 1995; 21: 537-43.
10. Mills KC, Serotonin syndrome. Am Fam Physician 1995; 52: 1475-82.
11. Sporer KA. The serotonin syndrome. Drug Saf 1995; 13: 94-103.
12. Kojima H, Terao T, Yoshimura R. Serotonin syndrome during clomipramine and lithium treatment. Am J Psychiatry 1993; 150: 1897.
13. Cano-Muñoz JL, Montejo-Iglesias ML, Yanez-Saez RM, Galvez-Borrero IM. Possible serotonin syndrome following the combined administration of clomipramine and alprazolam J Clin Psychiatry 1995; 56: 122-3.
14. Boix F, Fernandez-Teruel A, Escoriuhuela RM. Handling-habituation prevents the effects of diazepam and alprazolam on brain serotonin levels in rats. Behav Brain Res 1990; 36: 209-15.
15. McMillen BA, Woclen MH, Kiney SW. Interactions between arylpiperazine and benzodiazepine anxiolytic function, Eur J Pharmacol 1990; 183: 162-3.
16. Lejoyeux M, Fineyre F, Adès J. The serotonin syndrome. Am J Psychiatry 1992; 149: 1410-1.
17. Lenzi A, Raffaelli S, Marazziti D. Serotonin syndrome-like symptoms in patient with obsessive compulsive disorders, following inappropriate increase in fluvoxamine dosage. Pharmacopsychiatry 1993; 26: 100-1.
18. Lejoyeux M, Rouillon F, Adès J. Prospective evaluation of the serotonin syndrome in depressed patients treated with clomipramine. Acta Psychiatr Scand 1993; 88: 369-71.
19. Wallnöfer A, Guentert TW, Eckernäs SA. Moclobemide and fluvoxamine co-administration: a prospective study in healthy volunteers to investigate the potential development of the serotonin syndrome. Hum Psychopharmacol 1995; 10: 25-31
20. Lair D, Raucoules A, Bernardet R, Meynard JA, Sanchez MF. Syndrome sérotoninergique. Nervure 1994; 7: 9-12.
21. Nierenberg DW, Sembrebon M. The central nervous systeme serotonin syndrome. Clin Pharmacol Ther 1993; 53: 84-8.
22. Ohman R, Spigset O. Serotonin syndrome induced by fluvoxamine-lithium interaction. Pharmacopsychiatry 1993; 26: 263-4.
23. Corkeron MA, Serotonin syndrome - a potentially fatal complication of antidepressant therapy. Med J Aust 1995; 163: 481-2.
24. Power BM, Pinder M, Hackett LP, Ilett KF. Fatal serotonin syndrome following a combined overdose of moclobemide, clomipramine and fluoxetine. Anaesth Intensive Care 1995; 23: 499-502.
25. Peorson HP. Interaction of fluoxetine with carbamazepine. J Clin Psychiatry 1990; 51: 126-8.
26. Uchitomi Y, Yamawaki S, Hide I, Yokota N, Havakaxa H, Sarai K. Chronic lithium treatment enhances the 5HT 1a mediated serotonin syndrome produced by 8 OH-DPAT via catecholaminergic system; not via post synoptic 5HT1a receptors. Psychopharmacology 1988; 96, suppl. 376, abstr no 34-0151.
27. Bauer M. The combined used of lithium and SSR1. J Serotonin Res 1995; 2: 69-76.
28. Hendrickx B, FLoris M. A controled pilot study of the combination of fluvoxamine and lithium. Curr Ther Res 1991; 49: 106-10.
29. Pope HG, McElroy SL, Nixon RA. Possible serotonin syndrome between fluoxetine and lithium in refractory depression. Am J Psychiatry 1988; 145: 1292-4.
30. Hawley CJ, Roberts AG, Walken MH. Tolerability of combined treatment with lithium and paroxetine: 19 cases treated under open conditions. J Psychopharmacol 1994; 8: 266-7.
31. Dinan JG, Lithium augmentation on sertraline resistant depressions : a preliminary dose response study. Acta Psychiatr Scand 1993; 88: 300-1.
32. Skop BP, Finkelstein JA, Mareth TR, Magoan TR, Brown TM. The serotonin syndrome associated with poroxetine; an over the counter cold remedy, and vascular disease. Am J Emerg Med 1994; 12: 642-4.
33. Brannan SK, Talley BJ, Bowden CL. Sertraline and isocarboxazid caused a serotonin syndrome. J Clin Psychopharmacol 1994; 14: 144-5.
34. Ooi TK, The serotonin syndrome. Anaesthesia 1991; 46: 507-8.
35. Ruiz F. Fluoxetine and the serotonin syndrome. Ann Emerg Med 1994; 24: 983-5.
36. Lappin RL, Auchingloss EL. Treatment of the serotonin syndrome with cyproheptadine. N Engl J Med 1994; 331: 1021-2.
37. Graber MA, Hoens TB, Perry PJ. Sertraline-phenelzine drug interaction: a serotonin syndrome reaction. Ann Pharmacotherapy 1994; 28: 732-5.
38. Sauter D, Macneil P, Weinstein E, Azar A. Phenelzine sulfate-dextromethorphan interaction: a case report. Vet Hum Toxicol 1991; 33: 365-6.
39. Rivers N, Horner B. Possible lethal interaction between nardil and dextromethorphan. Can Med Assoc J 1970; 103: 85.
40. Tackley RM Tregaski B. Fatal disseminants intravascular coagulation following a monoamine oxydase inhibitor/tricyclic interaction. Anaesthesia 1987; 42: 760-3.
41. Brennan D, Mac Manus M, Howe J. Neuroleptic malignant syndrome without neuroleptics. Br J Psychiatry 1988; 152: 578-9.
42. Kline SS, Mauro LS, Scala Barnett DM, Zick D. Serotonin syndrome versus neuroleptic malignant syndrome as a cause of death. Clin Pharm 1989; 8: 510-4.
43. Beasley CM, Masica DN, Heiligenstein JH. Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine. Clinical data and preclinical findings. J Clin Psychopharmacol 1993; 13: 312-20.